This inventor holds 1 USPTO granted patent. Top assignee: Csl Behring Gmbh. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Christian Kannemaier: Innovator in Blood Clotting Research
Introduction
Christian Kannemaier is a notable inventor based in Giessen, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of blood clotting. His work focuses on developing innovative solutions to improve blood coagulation therapies.
Latest Patents
Kannemaier holds a patent for an inhibitory monoclonal antibody against blood clotting factor VII-activating protease. This monoclonal antibody inhibits the blood clotting factor VII-activating protease and its proenzyme. The patent describes a method for producing a suitable monoclonal antibody through the hybridoma cell line DSM ACC 2533. The application of this inhibitory monoclonal antibody is crucial for stabilizing blood clotting preparations and reducing blood coagulability.
Career Highlights
Christian Kannemaier is currently associated with Csl Behring GmbH, where he continues to advance his research in blood coagulation. His work has the potential to significantly impact the medical field by providing new therapeutic options for patients with clotting disorders.
Collaborations
Some of his notable coworkers include Hans-Arnold Stoehr and Fumie Nakazawa, who have collaborated with him on various research projects.
Conclusion
Christian Kannemaier's innovative work in the development of monoclonal antibodies represents a significant advancement in blood clotting research. His contributions are paving the way for improved therapeutic strategies in managing blood coagulation disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile